Mendelian randomization identifies proteins involved in neurodegenerative diseases - Takeaways - MDSpire

Mendelian randomization identifies proteins involved in neurodegenerative diseases

  • By

  • Lazaros Belbasis

  • Sam Morris

  • Cornelia van Duijn

  • Derrick Bennett

  • Robin Walters

  • March 3, 2025

  • 0 min

Share

  • 1

    This study identified protein associations with neurodegenerative diseases using large-scale genetic and proteomic data.

  • 2

    A total of 169 statistically significant protein-disease associations were found, with 23 linked to novel genetic loci.

  • 3

    The analysis revealed that APOE abundance is associated with brain volume changes and white matter hyper-intensities.

  • 4

    Newly associated proteins indicated roles for complement, microglia, and lysosomes in Alzheimer's disease pathology.

  • 5

    The study highlights the potential of combining genomic and proteomic data to uncover disease mechanisms and therapeutic targets.

Original Source(s)

Mendelian randomization identifies proteins involved in neurodegenerative diseases

  • by Lazaros Belbasis, Sam Morris, Cornelia van Duijn, Derrick Bennett, Robin Walters

  • March 3, 2025

Related Content

Editorial: Diffusion-weighted imaging: advances and implementations in neurology

Advancing rehabilitation in Parkinson’s disease through virtual reality: a narrative review

Acceptability of Technologies to Support Early Dementia Detection: Qualitative Study With the Boston University Alzheimer’s Disease Center Cohort